Masimo Faces Sanctions Bid Over Discovery In FCA Fight

Law360, New York (September 18, 2013, 3:21 PM EDT) -- Patient-monitoring tech firm Masimo Corp. withheld evidence in a False Claims Act case over Medicare reimbursements for allegedly defective medical devices, relators in the case told a California federal judge in a motion for sanctions on Tuesday.

The relators, former Masimo sales representatives selling the noninvasive hemoglobin devices called Radical-7, Pronto and Pronto-7, say that Masimo, which is accused of fraudulently causing an array of government programs to pay reimbursements for defective hemoglobin measurement devices, did not cooperate with discovery requests about details of its sales....
To view the full article, register now.




Case Information

Case Title

United States et al v. Masimo Corporation

Case Number



California Central

Nature of Suit

Other Statutory Actions


Cormac J. Carney

Date Filed

October 29, 2010

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.